Quantification of the response to miltefosine treatment for visceral leishmaniasis by QT-NASBA. (Q38967587)

8 September 2017

Quantification of the response to miltefosine treatment for visceral leishmaniasis by QT-NASBA. (English)

1 reference

8 September 2017

visceral leishmaniasis

1 reference

1 reference

Wendy F van der Meide

2

object named as

van der Meide WF

1 reference

8 September 2017

de Vries PJ

1

1 reference

8 September 2017

Godfried MH

3

1 reference

8 September 2017

Schallig HD

4

1 reference

8 September 2017

Dinant HJ

5

1 reference

8 September 2017

Faber WR

6

1 reference

8 September 2017

6 May 2006

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

8 September 2017

1 reference

8 September 2017

100

1 reference

8 September 2017

12

1 reference

8 September 2017

1183-1186

1 reference

Miltefosine to treat leishmaniasis

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.01.002

Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.01.002

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.01.002

Oral miltefosine for Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.01.002

Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.01.002

10.1016/J.TRSTMH.2006.01.002

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference